The selective synthesis of metallanucleosides and metallanucleotides: A new tool for the functionalization of nucleic acids

Chemistry - A European Journal

Volumn 18, Issue 40, 2012, Pages 12603-12608

  Martín Ortíz, Mamen ^a   Gõmez Gallego, Mar ^a   Ramírez De Arellano, Carmen ^b   Sierra, Miguel A ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b UNIVERSITY OF VALENCIA   (Spain)

Author keywords

cancer; iridium; metalation; metallanucleotides; nucleobases; rhodium

Indexed keywords

CANCER; FUNCTIONALIZATIONS; FUNCTIONALIZED; METALATIONS; METALLANUCLEOTIDES; NUCLEOBASES; SELECTIVE SYNTHESIS;

IRIDIUM; RHODIUM;

NUCLEIC ACIDS;

DNA; IRIDIUM; METAL; NUCLEIC ACID; PURINE NUCLEOSIDE; PURINE NUCLEOTIDE; RHODIUM; RNA;

ARTICLE; BASE PAIRING; CHEMISTRY; NUCLEOTIDE SEQUENCE; SYNTHESIS;

BASE PAIRING; BASE SEQUENCE; DNA; IRIDIUM; METALS; NUCLEIC ACIDS; PURINE NUCLEOSIDES; PURINE NUCLEOTIDES; RHODIUM; RNA;

EID: 84867048379     PISSN: 09476539     EISSN: 15213765     Source Type: Journal    
DOI: 10.1002/chem.201202327     Document Type: Article

References (81)

1. S. J. Lippard, J. M. Berg, Principles of Bioinorganic Chemistry, University Science Books, Mill Valley, CA, 1994
2. I. Bertini, H. B. Gray, S. J. Lippard, J. S. Valentine, Bioinorganic Chemistry, University Science Books, Mill Valley, CA, 1994
3. Metal Complex-DNA Interaction (Eds.:, N. Hadjiliadis, E. Sletten,), Wiley: Chichester, U.K., 2009
4. A. Houlton, Adv. Inorg. Chem. 2009, 53, 87
5. B. Lippert, Coord. Chem. Rev. 2000, 200, 487; For DNA binding with transition-metal species, see
6. V. Brabec, O. Nováková, Drug Resist. Updates 2006, 9, 111.
7. S. Ibañez, F. M. Alberti, P. J. Sanz Miguel, B. Lippert, Chem. Eur. J. 2011, 17, 9283
8. S. Ibañez, F. M. Alberti, P. J. Sanz Miguel, B. Lippert, Inorg. Chem. 2011, 50, 10439
9. J. Bogojeski, Z. D. Bugarcic, R. Puchta, R. van Eldik, Eur. J. Inorg. Chem. 2010, 5439
10. M. A. Galindo, D. Amantia, A. Martinez-Martinez, W. Clegg, R. W. Harrington, V. Moreno Martinez, A. Houlton, Inorg. Chem. 2009, 48, 11085
11. M. Garijo Anorbe, T. Welzel, B. Lippert, Inorg. Chem. 2007, 46, 8222; With other transition metals
12. C. Deng, L. Zhou, Inorganica Chimica Acta 2011, 370, 70
13. M. A. Galindo, D. Amantia, A. Martinez Martinez, W. Clegg, R. W. Harrington, V. Moreno Martinez, A. Houlton, Inorg. Chem. 2009, 48, 10295
14. H. T. Chifotides, K. R. Dunbar, Acc. Chem. Res. 2005, 38, 146
15. H. T. Chifotides, K. M. Koshlap, L. M. Pérez, K. R. Dunbar, J. Am. Chem. Soc. 2003, 125, 10703
16. C. Pearson, A. L. Beauchamp, Inorg. Chem. 1998, 37, 1242.
17. T. Reissner, S. Schneider, S. Schorr, T. Carell, Angew. Chem. 2010, 122, 3142
18. Angew. Chem. Int. Ed. 2010, 49, 3077
19. Y. Jung, S. J. Lippard, Chem. Rev. 2007, 107, 1387
20. D. Wang, S. J. Lippard, Nat. Rev. Drug Discovery 2005, 4, 307
21. H. Zorbas, B. K. Keppler, ChemBioChem 2005, 6, 1157
22. Z. H. Siddik, Oncogene 2003, 22, 7265
23. T. W. Hambley, J. Chem. Soc. Dalton Trans. 2001, 2711
24. E. R. Jamieson, S. J. Lippard, Chem. Rev. 1999, 99, 2467
25. B. Lippert, In Cisplatin: Chemistry and Biochemistry of a leading Anticancer Drug; (Ed.,; B. Lippert,), HVCA and Wiley-VCH: Zurich and Weinheim, 1999
26. B. Lippert, Coord. Chem. Rev. 1999, 182, 263.
27. G. Sava, A. Bergamo, P. J. Dyson, Dalton Trans. 2011, 40, 9069
28. H. Chen, J. A. Parkinson, S. Parsons, R. A. Coxall, R. O. Gould, P. J. Sadler, J. Am. Chem. Soc. 2002, 124, 3064
29. F. Wang, J. Xu, A. Habtemariam, J. Bella, P. J. Sadler, J. Am. Chem. Soc. 2005, 127, 17734
30. M. J. Clarke, F. Zhu, D. R. Frasca, Chem. Rev. 1999, 99, 2511.
31. Modified Nucleosides in Biochemistry Biotechnology and Medicine; (Ed.:, P. Herdewijn,), Wiley-VCH, Weinheim, Germany, 2008
32. A. Mieczkowski, V. Roy, L. A. Agrofoglio, Chem. Rev. 2010, 110, 1828
33. M. Legraverend, D. S. Grierson, Bioorg. Med. Chem. 2006, 14, 3987
34. D. Schlawe, A. Majdalani, J. Velcicky, E. Heßler, T. Wieder, A. Prokop, H.-G. Schmalz, Angew. Chem. 2004, 116, 1763
35. Angew. Chem. Int. Ed. 2004, 43, 1731.
36. L.-L. Gundersen, J. Nissen-Meyer, D. Spilsberg, J. Med. Chem. 2002, 45, 1383
37. G. Andresen, L.-L. Gundersen, J. Nissen-Meyer, F. Rise, B. Spilsberg, Bioorg. Med. Chem. Lett. 2002, 12, 567
38. M. Hocek, A. Holy, I. Votruba, H. Dvorakova, J. Med. Chem. 2000, 43, 1817
39. A. K. Bakkestuen, L.-L. Gundersen, G. Langli, F. Liu, J. M. J. Nolsøe, Bioorg. Med. Chem. Lett. 2000, 10, 1207
40. A. J. Cocuzza, D. R. Chidester, S. Culp, L. Fitzgerald, P. Gilligan, Bioorg. Med. Chem. Lett. 1999, 9, 1063.
41. A. Brathe, G. Andresen, L.-L. Gundersen, K. E. Malterud, F. Rise, Bioorg. Med. Chem. 2002, 10, 1581
42. A. Brathe, G. Andresen, L.-L. Gundersen, F. Rise, A. B. Eriksen, A. V. Vollsness, L. Wang, Tetrahedron 1999, 55, 211.
43. M. Hocek, P. Naus, R. Pohl, I. Votruba, P. A. Furman, P. M. Tharnish, M. J. Otto, J. Med. Chem. 2005, 48, 5869
44. A. K. Bakkestuen, L. L. Gundersen, B. T. Utenova, J. Med. Chem. 2005, 48, 2710
45. I. Hirao, T. Ohtsuki, T. Fujiwara, T. Mitsui, T. Yokogawa, T. Okuni, H. Nakayama, K. Takio, T. Yabuki, T. Kigawa, K. Kodama, T. Yokogawa, K. Nishikawa, S. Yokoyama, Nature Biotechnol. 2002, 20, 177.
46. B. Lippert, P. J. Sanz Miguel, Chem. Soc. Rev. 2011, 40, 4475
47. E. Zangrando, M. Casanova, E. Alessio, Chem. Rev. 2008, 108, 4979.
48. S. Verma, A. K. Mishra, J. Kumar, Acc. Chem. Res. 2010, 43, 79
49. C. S. Purohit, S. Verma, J. Am. Chem. Soc. 2006, 128, 400
50. I. B. Rother, E. Freisinger, A. Erxleben, B. Lippert, Inorg. Chim. Acta 2000, 300-302, 339-352; With Zn
51. J. An, R. P. Fiorella, S. Geib, J. Rosi, L. Nathaniel, J. Am. Chem. Soc. 2009, 131, 8401; Trinuclear with Rh and Ir
52. K. Yamanari, R. Ito, S. Yamamoto, T. Konno, A. Fuyuhiro, M. Kobayashi, R. Arakawa, Dalton Trans. 2003, 380
53. P. Annen, S. Schildberg, W. S. Sheldrick, Inorg. Chim. Acta 2000, 307, 115
54. H. Chen, S. Ogo, R. H. Fish, J. Am. Chem. Soc. 1996, 118, 4993; Trinuclear with Pt
55. B. Longato, L. Pasquato, A. Mucci, L. Schenetti, E. Zangrando, Inorg. Chem. 2003, 42, 7861
56. X. Zhu, E. Rusanov, R. Kluge, H. Schmidt, D. Steinborn, Inorg. Chem. 2002, 41, 2667; Macrochelates
57. B. Knobloch, A. Mucha, B. P. Operschall, H. Sigel, M. Jezowska-Bojczuk, H. Kozlowski, R. K. O. Sigel, Chem. Eur. J. 2011, 17, 5403.
58. M. Albrecht, Chem. Rev. 2010, 110, 576
59. T. W. Lyons, M. S. Sanford, Chem. Rev. 2010, 110, 1147
60. L. Ackermann, R. Vicente, A. R. Kapdi, Angew. Chem. 2009, 121, 9976
61. Angew. Chem. Int. Ed. 2009, 48, 9792
62. X. Chen, K. M. Engle, D.-H. Wang, J.-Q. Yu, Angew. Chem. 2009, 121, 5196
63. Angew. Chem. Int. Ed. 2009, 48, 5094
64. O. Daugulis, H.-Q. Do, D. Shabashov, Acc. Chem. Res. 2009, 42, 1074
65. J. C. Lewis, R. G. Bergman, J. A. Ellman, Acc. Chem. Res. 2008, 41, 1013
66. D. Alberico, M. E. Scott, M. Lautens, Chem. Rev. 2007, 107, 174.
67. Facile breakage of the glycosidic bond in metal-mediated C-H activation conditions has been reported. See, for example:, T. E. Storr, C. G. Baumann, R. J. Thatcher, S. De Ornellas, A. C. Whitwood, I. J. S. Fairlamb, J. Org. Chem. 2009, 74, 5810.
68. C. L. Chepanoske, C. R. Langelier, N. H. Chmiel, S. S. David, Org. Lett. 2000, 2, 1341
69. A. K. Ogawa, Y. Wu, D. L. McMinn, J. Liu, P. G. Schultz, F. E. Romesberg, J. Am. Chem. Soc. 2000, 122, 3274
70. E. T. Kool, J. C. Morales, K. M. Guckian, Angew. Chem. 2000, 112, 1046
71. Angew. Chem. Int. Ed. 2000, 39, 990
72. J. C. Morales, E. T. Kool, J. Am. Chem. Soc. 2000, 122, 1001
73. J. C. Morales, E. T. Kool, J. Am. Chem. Soc. 1999, 121, 2323
74. D. L. McMinn, A. K. Ogawa, Y. Wu, J. Liu, P. G. Schultz, F. E. Romesberg, J. Am. Chem. Soc. 1999, 121, 11585.
75. Y. Boutadla, D. L. Davies, R. C. Jones, K. Singh, Chem. Eur. J. 2011, 17, 3438 and references therein.
76. H. Chen, J. A. Parkinson, R. E. Morris, P. J. Sadler, J. Am. Chem. Soc. 2003, 125, 173.
77. The N1 atom in 6-arylpurines has been recently used as the directing group in metal-catalyzed C-C arylations:, H.-M. Guo, l.-;L. Jiang, H.-Y. Niu, W.-H. Rao, L. Liang, R.-Z. Mao, D.-Y. Li, G.-R. Qu, Org. Lett. 2011, 13, 2008.
78. L. Li, W. W. Brennessel, W. D. Jones, J. Am. Chem. Soc. 2008, 130, 12414.
79. Ru-cyclometallated intermediates structurally related to the metal-nucleobases reported in this work were proposed to be involved as key intermediates in the catalytic cycles of C-C arylations, see:, M. K. Lakshman, A. C. Deb, R. R. Chamala, P. Pradhan, R. Pratap, Angew. Chem. 2011, 123, 11602
80. Angew. Chem. Int. Ed. 2011, 50, 11400.
81. J. D. Blakemore, N. D. Schley, D. Balcells, J. F. Hull, G. W. Olack, C. D. Incarvito, O. Eisenstein, G. W. Brudvig, R. H. Crabtree, J. Am. Chem. Soc. 2010, 132, 16017.